Researchers have discovered a key molecule that is responsible for the characteristic immature structure of blood vessels in malignant tumors.
If this molecule is switched off in mice, vessels normalize so that immune cells are better able to get to the tumor tissue from the bloodstream.
This significantly increases the effectiveness of immune therapies and, thus, considerably enhances the survival time of treated animals.
Post new comment